| Year |
Title |
Altmetric |
| 2022
|
The versatile role of HuR in Glioblastoma and its potential as a therapeutic target for a multi-pronged attack.
Advanced Drug Delivery Reviews.
181.
2022
|
|
| 2022
|
SRI-42127, a novel small molecule inhibitor of the RNA regulator HuR, potently attenuates glial activation in a model of lipopolysaccharide-induced neuroinflammation.
Glia.
70:155-172.
2022
|
|
| 2021
|
FGF23, a novel muscle biomarker detected in the early stages of ALS.
Scientific Reports.
11.
2021
|
|
| 2021
|
The pathogenic role of c-Kit+ mast cells in the spinal motor neuron-vascular niche in ALS.
Acta Neuropathologica Communications.
9.
2021
|
|
| 2021
|
Fat mass loss correlates with faster disease progression in amyotrophic lateral sclerosis patients: Exploring the utility of dual-energy xray absorptiometry in a prospective study.
PLoS ONE.
16.
2021
|
|
| 2021
|
Targeting the HuR oncogenic role with a new class of cytoplasmic dimerization inhibitors.
Cancer Research.
81:2220-2233.
2021
|
|
| 2021
|
13109 Phosphorylation state of Myristoylated Alanine-Rich C-Kinase Substrate Effector Domain mimetics determines its cytotoxicity in glioblastoma and macrophage model.
Journal of Clinical and Translational Science.
5:1-1.
2021
|
|
| 2021
|
A Nitroalkene Benzoic Acid Derivative Targets Reactive Microglia and Prolongs Survival in an Inherited Model of ALS via NF-κB Inhibition.
Neurotherapeutics.
18:309-325.
2021
|
|
| 2020
|
Wnt antagonist FRZB is a muscle biomarker of denervation atrophy in amyotrophic lateral sclerosis.
Scientific Reports.
10.
2020
|
|
| 2020
|
Randomized feasibility trial to assess tolerance and clinical effects of lithium in progressive multiple sclerosis.
Heliyon.
6.
2020
|
|
| 2020
|
Schwann cells orchestrate peripheral nerve inflammation through the expression of CSF1, IL-34, and SCF in amyotrophic lateral sclerosis.
Glia.
68:1165-1181.
2020
|
|
| 2020
|
The vitamin D activator CYP27B1 is upregulated in muscle fibers in denervating disease and can track progression in amyotrophic lateral sclerosis
2020
|
|
| 2019
|
Deletion of the RNA regulator HuR in tumor-associated microglia and macrophages stimulates anti-tumor immunity and attenuates glioma growth.
Glia.
67:2424-2439.
2019
|
|
| 2019
|
CD34 identifies a subset of proliferating microglial cells associated with degenerating motor neurons in ALS.
International Journal of Molecular Sciences.
20.
2019
|
|
| 2019
|
Quality of Care for Veterans With In-Hospital Stroke..
Federal practitioner : for the health care professionals of the VA, DoD, and PHS.
36:365-369.
2019
|
|
| 2019
|
Anti-cancer effects of the HuR inhibitor, MS-444, in malignant glioma cells.
Cancer Biology and Therapy.
20:979-988.
2019
|
|
| 2018
|
Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS.
JCI insight.
3.
2018
|
|
| 2018
|
Muscle microRNA signatures as biomarkers of disease progression in amyotrophic lateral sclerosis.
Neurobiology of Disease.
114:85-94.
2018
|
|
| 2018
|
Characterization of the transient middle cerebral artery occlusion model of ischemic stroke in a HuR transgenic mouse line..
Data in Brief.
16:1083-1090.
2018
|
|
| 2017
|
Transgenic expression of HuR increases vasogenic edema and impedes functional recovery in rodent ischemic stroke.
Neuroscience Letters.
661:126-131.
2017
|
|
| 2017
|
Hu antigen R (HuR) multimerization contributes to glioma disease progression.
Journal of Biological Chemistry.
292:16999-17010.
2017
|
|
| 2017
|
Astrocytic expression of the RNA regulator HuR accentuates spinal cord injury in the acute phase.
Neuroscience Letters.
651:140-145.
2017
|
|
| 2017
|
HuR promotes the molecular signature and phenotype of activated microglia: Implications for amyotrophic lateral sclerosis and other neurodegenerative diseases.
Glia.
65:945-963.
2017
|
|
| 2017
|
RNA Binding Protein Human Antigen R is Translocated in Astrocytes following Spinal Cord Injury and Promotes the Inflammatory Response.
Journal of Neurotrauma.
34:1249-1259.
2017
|
|
| 2015
|
Transforming growth factor beta (TGF-β) is a muscle biomarker of disease progression in ALS and correlates with smad expression.
PLoS ONE.
10.
2015
|
|
| 2014
|
Hu antigen R (HuR) is a positive regulator of the RNA-binding proteins TDP-43 and FUS/TLS: Implications for amyotrophic lateral sclerosis.
Journal of Biological Chemistry.
289:31792-31804.
2014
|
|
| 2014
|
Smads as muscle biomarkers in amyotrophic lateral sclerosis.
Annals of Clinical and Translational Neurology.
1:778-787.
2014
|
|
| 2014
|
Role of KSRP in control of type i interferon and cytokine expression.
Journal of Interferon and Cytokine Research.
34:267-274.
2014
|
|
| 2014
|
Expression of PRMT5 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth in vitro.
Journal of Neuro-Oncology.
118:61-72.
2014
|
|
| 2013
|
Epidemiological features of amyotrophic lateral sclerosis in a large clinic-based African American population
2013
|
|
| 2013
|
Mutant tristetraprolin: A potent inhibitor of malignant glioma cell growth.
Journal of Neuro-Oncology.
113:195-205.
2013
|
|
| 2013
|
Electromyography tests in patients with implanted cardiac devices are safe regardless of magnet placement.
Muscle and Nerve.
47:17-22.
2013
|
|
| 2012
|
KSRP: A checkpoint for inflammatory cytokine production in astrocytes.
Glia.
60:1773-1784.
2012
|
|
| 2012
|
Phosphoregulation of the RNA-binding protein Hu antigen R (HuR) by Cdk5 affects centrosome function.
Journal of Biological Chemistry.
287:32277-32287.
2012
|
|
| 2012
|
Sex hormone-dependent attenuation of EAE in a transgenic mouse with astrocytic expression of the RNA regulator HuR.
Journal of Neuroimmunology.
246:34-37.
2012
|
|
| 2011
|
The RNA-binding protein HuR promotes glioma growth and treatment resistance
2011
|
|
| 2011
|
Dermatomyositis and concomitant overlap myasthenic syndrome: A rare presentation.
Journal of The American Academy of Dermatology.
65.
2011
|
|
| 2009
|
Amyotrophic lateral sclerosis-linked mutant SOD1 sequesters Hu antigen R (HuR) and TIA-1-related protein (TIAR). Implications for impaired post-transcriptional regulation of vascular endothelial growth factor.
Journal of Biological Chemistry.
284:33989-33998.
2009
|
|
| 2009
|
Mutant copper-zinc superoxide dismutase associated with amyotrophic lateral sclerosis binds to adenine/uridine-rich stability elements in the vascular endothelial growth factor 3′-untranslated region.
Journal of Neurochemistry.
108:1032-1044.
2009
|
|
| 2008
|
Alterations in RNA-binding activities of IRES-regulatory proteins as a mechanism for physiological variability and pathological dysregulation of IGF-IR translational control in human breast tumor cells.
Journal of Cellular Physiology.
217:172-183.
2008
|
|
| 2008
|
Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells.
Cancer Research.
68:674-682.
2008
|
|
| 2007
|
Mutant Cu/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression
2007
|
|
| 2005
|
The ELAV RNA-stability factor HuR binds the 5′-untranslated region of the human IGF-IR transcript and differentially represses cap-dependent and IRES-mediated translation.
Nucleic Acids Research.
33:2962-2979.
2005
|
|
| 2005
|
Docking and rolling, a model of how the mitotic motor Eg5 works.
Journal of Biological Chemistry.
280:35684-35695.
2005
|
|
| 2005
|
Novel DNA-binding properties of the RNA-binding protein TIAR.
Nucleic Acids Research.
33:4507-4518.
2005
|
|
| 2005
|
IL-1β induces stabilization of IL-8 mRNA in malignant breast cancer cells via the 3′ untranslated region: Involvement of divergent RNA-binding factors HuR, KSRP and TIAR.
International Journal of Cancer.
113:911-919.
2005
|
|
| 2005
|
Anti-Hu antibody neuropathy: A clinical, electrophysiological, and pathological study
2005
|
|
| 2003
|
Tumor necrosis factor α induces angiogenic factor up-regulation in malignant glioma cells: A role for RNA stabilization and HuR.
Cancer Research.
63:4181-4187.
2003
|
|
| 2003
|
Stepping and stretching. How kinesin uses internal strain to walk processively..
Journal of Biological Chemistry.
278:18550-18556.
2003
|
|
| 2002
|
Measuring kinesin's first step.
Journal of Biological Chemistry.
277:36731-36739.
2002
|
|
| 2002
|
Human cytomegalovirus infection and expression in human malignant glioma.
Cancer Research.
62:3347-3350.
2002
|
|
| 2002
|
Porphyria presenting with bilateral radial motor neuropathy: Evidence of a novel gene mutation.
Neurology.
58:1118-1121.
2002
|
|
| 2001
|
Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells..
Journal of Clinical Investigation.
108:1657-1665.
2001
|
|
| 2001
|
ATP Reorients the Neck Linker of Kinesin in Two Sequential Steps.
Journal of Biological Chemistry.
276:40167-40174.
2001
|
|
| 2001
|
HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3′ untranslated regions of cytokine and angiogenic factor mRNAs.
Cancer Research.
61:2154-2161.
2001
|
|
| 2001
|
Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells.
Journal of Clinical Investigation.
108:1657-1665.
2001
|
|
| 2000
|
Analysis of the 5' end of the mouse Elavl1 (mHuA) gene reveals a transcriptional regulatory element and evidence for conserved genomic organization.
Gene.
242:125-131.
2000
|
|
| 2000
|
RNA-binding analyses of HuC and HuD with the VEGF and c-myc 3'-untranslated regions using a novel ELISA-based assay..
Nucleic Acids Research.
28.
2000
|
|
| 1999
|
Hu antigen specificities of ANNA-I autoantibodies in paraneoplastic neurological disease.
Journal of Autoimmunity.
13:435-443.
1999
|
|
| 1998
|
HuR, a novel target of anti-Hu antibodies, is expressed in non-neural tissues.
Journal of Neuroimmunology.
92:152-159.
1998
|
|
| 1998
|
Charcot-Marie-Tooth phenotype produced by a duplicated PMP22 gene as part of a 17p trisomy-translocation to the X chromosome.
1998
|
|
| 1998
|
Localization of HuC (ELAVL3) to chromosome 19p13.2 by fluorescence in situ hybridization utilizing a novel tyramide labeling technique.
Genomics.
53:296-299.
1998
|
|
| 1997
|
Neuron-specific hel-N1 and HuD as novel molecular markers of neuroblastoma: a correlation of HuD messenger RNA levels with favorable prognostic features..
Clinical Cancer Research.
3:1859-1865.
1997
|
|
| 1997
|
Differential expression of the neuroendocrine genes Hel-N1 and HuD in small-cell lung carcinoma: evidence for down-regulation of HuD in the variant phenotype..
International Journal of Cancer.
74:378-382.
1997
|
|
| 1996
|
Localization of human elav-like neuronal protein 1 (Hel-N1) on chromosome 9p21 by chromosome microdissection polymerase chain reaction and fluorescence in situ hybridization.
Genomics.
36:189-191.
1996
|
|
| 1996
|
Cloning the 5' flanking region of neuron-specific Hel-N1: evidence for positive regulatory elements governing cell-specific transcription..
Brain Research.
723:141-147.
1996
|
|
| 1996
|
Expression of Hel-N1 and Hel-N2 in small-cell lung carcinoma..
Annals of Neurology.
39:679-681.
1996
|
|
| 1994
|
Hel-N2: a novel isoform of Hel-N1 which is conserved in rat neural tissue and produced in early embryogenesis..
Gene.
151:261-265.
1994
|
|
| 1994
|
Mammalian homologs of Drosophila ELAV localized to a neuronal subset can bind in vitro to the 3' UTR of mRNA encoding the Id transcriptional repressor.
1994
|
|
| 1994
|
Autoantibodies against the Hel‐N1 RNA‐binding protein among patients with lung carcinoma: An association with type I anti–neuronal nuclear antibodies.
Annals of Neurology.
36:200-205.
1994
|
|
| 1993
|
Hel-N1: an autoimmune RNA-binding protein with specificity for 3' uridylate-rich untranslated regions of growth factor mRNAs.
Molecular and Cellular Biology.
13:3494-3504.
1993
|
|
| 1993
|
Hel-N1: an autoimmune RNA-binding protein with specificity for 3' uridylate-rich untranslated regions of growth factor mRNAs..
Molecular and Cellular Biology.
13:3494-3504.
1993
|
|
| 1991
|
MRI reveals multiple reversible cerebral lesions in an attack of acute intermittent porphyria..
Neurology.
41:1300-1302.
1991
|
|
| 1987
|
Microinjection of a benzodiazepine into substantia nigra elevates kindled seizure threshold..
Brain Research.
423:261-268.
1987
|
|
